Acurx Pharmaceuticals, Inc. (ACXP) vs Cardio Diagnostics Holdings, Inc. (CDIO)
A side-by-side comparison of Acurx Pharmaceuticals, Inc. and Cardio Diagnostics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACXP
Acurx Pharmaceuticals, Inc.
$1.31HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CDIO
Cardio Diagnostics Holdings, Inc.
$2.06HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACXP vs CDIO
growth of $100 · dividends reinvested · last 5yACXP -98.5% (-57.0%/yr)CDIO -99.3% (-62.9%/yr)ACXP compounded faster over this window
ACXP CDIO
ACXP vs CDIO: by the numbers
- •CDIO is the larger company ($6M vs $6M market cap).
- •Both run net losses; ACXP's is the smaller (0.00% vs -44771.83% net margin).
Metrics side by side
Valuation
| Metric | ACXP | CDIO |
|---|---|---|
| P/S ratio | N/A | 421.90 |
| P/B ratio | 0.69 | 0.82 |
Profitability
| Metric | ACXP | CDIO |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -43737.46% |
| Net margin | 0.00% | -44771.83% |
| ROE | -92.08% | -87.12% |
| ROIC | -94.08% | -82.84% |
Growth (annualized)
| Metric | ACXP | CDIO |
|---|---|---|
| Total return CAGR (5Y) | -57.41% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.